| 摘要 |
Disclosed is the use of therapeutically effective amounts of ascorbic acid, ascorbyl palmitate, beta-, gamma-, delta-tocopherol-mix, beta-carotene, biotin, calcium ascorbate, calcium glycinate, caroteinoid mix (alpha-carotene, lutein, zea-cryptoxanthin), cholecalciferol, chromium glycinate, citrus bioflavonoids, coenzyme Q10, copper glycinate, cyanocobalamin, d-alpha-tocopherol, d-calcium pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-carnitine, L-cysteine, L-Iysine, L-proline, L-selenomethionine, magnesium ascorbate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, pycnogenol, pyridoxine, riboflavin, thiamine, and zinc glycinate in the production of a composition for lowering plasma concentration of a lipoprotein or other metabolic risk factor in a mammal. (62) Divided Out of 525390
|
